查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2022801

全球精密醫療設備市場：市場規模、佔有率和趨勢分析（按器材類型、技術、應用、最終用戶和連接方式分類）—市場機會分析和產業預測（2026-2036 年）

Precision Medical Devices Market Size, Share & Trends Analysis by Device Type (Diagnostic Devices, Monitoring Devices), Technology, Application, End User, and Connectivity - Global Opportunity Analysis & Industry Forecast (2026-2036)
出版日期: | 出版商: Meticulous Research | 英文 310 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

全球精準醫療設備市場預計將從2026年的537億美元成長至2036年的984億美元，預測期間（2026-2036年）複合年成長率（CAGR）為6.2%。這項市場成長主要受多種結構性因素驅動，包括全球精準醫療的模式轉移，以及人工智慧、機器人和先進感測器等技術加速融入臨床設備平台。精準醫療透過基因組學、蛋白質組學和生理學數據，針對個別患者特徵最佳化臨床干預，其在全球範圍內的普及從根本上重塑了對醫療設備的需求，要求診斷系統能夠在分子水平上對疾病進行表徵，醫療設備能夠以前所未有的解剖學精度提供個性化治療。

隨著醫療產業從被動的標準化模式轉向預防性的個人化干預，全球精準醫療設備市場正經歷根本性的結構性變革。這項變革的驅動力在於高解析度資料流和先進分析技術的融合，使醫療設備從被動的工具轉變為臨床照護中積極主動的智慧夥伴。產業正朝著互聯生態系統發生重大轉變，穿戴式感測器和遠端監測平台能夠提供持續、長期的患者健康洞察，取代碎片化的治療方案。此外，機器人輔助手術和影像引導介入技術的快速發展正在重新定義手術精確度，使微創手術能夠達到亞毫米級的精確度。這種動態變化正在推動對人工智慧驅動的診斷平台和個人化植入式醫療設備的需求持續成長。這些設備將幫助臨床醫生實現更高的診斷準確率和治療效果，最終改善各種急性疾病患者的治療效果。

目錄

第1章：引言

第2章 分析方法

第3章執行摘要

第4章 市場概覽

  • 市場動態
    • 促進因素
      • 精準醫療和個人化醫療的廣泛應用
      • 對微創手術的需求日益成長
      • 影像、機器人和感測器技術的進步
      • 慢性病盛行率增加
    • 抑制因子
      • 先進精密設備高成本
      • 複雜的監管核准流程
      • 與醫療資訊系統整合面臨的挑戰
    • 機會
      • 穿戴式和遠端監控設備的成長
      • 人工智慧診斷設備的擴展
      • 新興市場採用率的擴大
      • 開發個人化植入式設備
    • 任務
      • 數據準確性和互通性問題
      • 連網型設備的網路安全風險
  • 科技趨勢
    • 人工智慧和機器學習在醫療設備的應用
    • 機器人手術與電腦輔助手術
    • 先進的成像技術
    • 生物感測器和穿戴式技術
    • 3D列印和個人化植入
  • 價值鏈分析
    • 組件供應商（感測器、晶片、材料）
    • 設備製造商
    • 軟體和人工智慧平台提供商
    • 醫療服務提供方
    • 患者和最終用戶
  • 法規和標準的發展趨勢
    • FDA醫療設備法規
    • 歐盟醫療器材法規和CE標誌
    • ISO標準（ISO 13485、IEC 60601）
    • 資料隱私法規（HIPAA、GDPR）
  • 波特五力分析

第5章：精密醫療設備市場：依器材類型分類（主要細分市場）

  • 診斷設備
    • 診斷影像系統（MRI、CT、超音波）
    • 分子和基因組診斷設備
    • 即時診斷設備
  • 用於治療的醫療設備
    • 雷射治療設備
    • 放射治療設備
    • 藥物輸送系統
  • 監控設備
    • 持續血糖監測（CGM）
    • 心臟監測設備
    • 遠端患者監護系統
    • 穿戴式健康設備
  • 外科和介入醫療設備
    • 機器人手術系統
    • 影像導引手術設備
    • 微創手術器械
  • 植入式醫療設備
    • 心臟植入（心律調節器、ICD）
    • 整形外科植入
    • 神經刺激裝置
    • 個性化/3D列印植入
  • 其他精密醫療設備

第6章：精準醫療設備市場：依技術分類

  • 人工智慧和機器學習
  • 機器人與自動化
  • 感測器和生物感測器技術
  • 成像技術
  • 3D列印與積層製造

第7章：精密醫療設備市場：依應用領域分類

  • 循環系統疾病
  • 瘤
  • 神經系統疾病
  • 整形外科
  • 糖尿病管理
  • 呼吸護理
  • 其他

第8章：精準醫療設備市場：依最終用戶分類

  • 醫院和診所
  • 門診手術中心
  • 診斷檢查室
  • 居家醫療
  • 研究和學術機構

第9章：精密醫療設備市場：精準度等級（詳細分類）

  • 標準精密醫療設備
  • 高精度醫療設備
  • 超高精度/客製化設備

第10章：精密醫療設備市場：依連接方式分類

  • 獨立設備
  • 聯網/物聯網設備
  • 雲端連線裝置

第11章：精準醫療設備市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 瑞士
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印尼
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 智利
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • UAE
    • 沙烏地阿拉伯
    • 南非
    • 土耳其
    • 以色列
    • 其他中東和非洲國家

第12章 競爭格局

  • 關鍵成長策略
  • 競爭性標竿分析
  • 競爭對手儀錶板
    • 產業領導者
    • 市場差異化因素
    • 先鋒公司
    • 新興企業
  • 主要企業市場排名和定位分析（2025 年）

第13章：公司簡介

  • Medtronic plc
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Philips Healthcare
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Stryker Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson（MedTech）
  • Becton, Dickinson and Company（BD）
  • Roche Diagnostics
  • Dexcom, Inc.
  • Zimmer Biomet Holdings
  • ResMed Inc.
  • Masimo Corporation

第14章附錄

簡介目錄
Product Code: MRHC - 1041890

Precision Medical Devices Market Size, Share & Trends Analysis by Device Type (Diagnostic Devices, Monitoring Devices, Therapeutic Devices, Surgical Devices, Implantable Devices), Technology (AI, Robotics, Sensors, 3D Printing), Application, End User, and Connectivity - Global Opportunity Analysis & Industry Forecast (2026-2036)

According to the research report titled, 'Precision Medical Devices Market Size, Share, and Trends Analysis by Device Type (Diagnostic Devices, Monitoring Devices, Therapeutic Devices, Surgical & Interventional Devices, Implantable Devices), Technology (AI & ML, Robotics & Automation, Sensor & Biosensor, Imaging, 3D Printing), Application (Cardiology, Oncology, Neurology, Orthopedics, Diabetes Management, Respiratory Care), End User (Hospitals & Clinics, ASCs, Diagnostic Labs, Home Healthcare, Research Institutes), Connectivity (Standalone, Connected/IoT, Cloud-Integrated), and Geography-Global Forecast to 2036,' the global precision medical devices market is projected to reach USD 98.4 billion by 2036 from USD 53.7 billion in 2026, growing at a CAGR of 6.2% during the forecast period (2026-2036). The growth of this market is primarily driven by the converging structural forces of the global precision medicine paradigm shift and the accelerating technology integration of artificial intelligence, robotics, and advanced sensors into clinical device platforms. The global adoption of precision medicine-which tailors clinical interventions to individual patient characteristics defined by genomic, proteomic, and physiological data-is fundamentally reshaping requirements for medical devices, demanding diagnostic systems capable of molecular-level disease characterization and therapeutic devices capable of delivering individualized treatment at anatomical precision levels previously unattainable.

The global precision medical devices market is undergoing a profound structural transformation as the healthcare industry moves from a reactive, one-size-fits-all model toward proactive, personalized interventions. This evolution is being catalyzed by the integration of high-resolution data streams with advanced analytics, enabling devices to transition from passive tools to active, intelligent partners in clinical care. The industry is witnessing a significant shift toward connected ecosystems where wearable sensors and remote monitoring platforms provide a continuous longitudinal view of patient health, replacing episodic clinical encounters. Furthermore, the rapid advancement of robotic-assisted surgery and image-guided interventions is redefining surgical precision, allowing for minimally invasive procedures with sub-millimeter accuracy. This dynamic shift ensures sustained demand for AI-enabled diagnostic platforms and personalized implantable devices that empower clinicians to achieve higher levels of diagnostic accuracy and therapeutic efficacy, ultimately improving patient outcomes across a wide range of chronic and acute conditions.

Market Segmentation

The global precision medical devices market is segmented by device type (diagnostic devices, monitoring devices, therapeutic devices, surgical & interventional devices, and implantable devices), technology (AI & ML, robotics & automation, sensor & biosensor technologies, imaging technologies, and 3D printing), application (cardiology, oncology, neurology, orthopedics, diabetes management, respiratory care, and others), end user (hospitals & clinics, ambulatory surgical centers, diagnostic laboratories, home healthcare settings, and research & academic institutes), connectivity (standalone, connected/IoT-enabled, and cloud-integrated), and geography. The study evaluation includes industry competitors and analyzes the market at the country level.

Based on Device Type

By device type, the diagnostic devices segment is expected to hold the largest share of the global precision medical devices market in 2026. This segment includes high-value imaging systems, molecular diagnostics, and point-of-care devices that are essential for early disease detection and characterization. Conversely, the monitoring devices segment, particularly wearable and remote patient monitoring systems, is projected to register the highest CAGR during the forecast period. This rapid growth is driven by the post-pandemic expansion of telehealth and the increasing demand for continuous physiological monitoring in chronic disease management. Surgical and interventional devices, including robotic platforms, also represent a significant and fast-growing segment as hospitals invest in technology to improve procedural precision and patient recovery times.

Based on Technology

By technology, the imaging technologies segment is expected to hold the largest share of the market in 2026. Advanced imaging remains the cornerstone of precision diagnostics, providing the anatomical and functional detail required for personalized treatment planning. However, the artificial intelligence and machine learning segment is projected to register the highest CAGR. AI is increasingly being integrated into diagnostic platforms to automate image interpretation, detect subtle pathologies, and provide predictive clinical decision support. Sensor and biosensor technologies are also witnessing rapid adoption, enabling the miniaturization of precision monitoring devices for home and wearable use.

Based on End User

By end user, the hospitals and clinics segment is expected to hold the largest share in 2026. The dominance of this sector is underpinned by the concentration of advanced diagnostic and surgical infrastructure in centralized healthcare facilities. Conversely, the home healthcare settings segment is projected to register the highest CAGR during the forecast period. This shift is fueled by the democratization of precision monitoring through smartphone-connected devices and the clinical trend toward decentralized care delivery. Ambulatory Surgical Centers (ASCs) also represent a growing segment, as they increasingly adopt precision surgical and interventional tools to offer cost-effective, high-quality outpatient procedures.

Geographic Analysis

In 2026, North America is expected to account for the largest share of the global precision medical devices market. The region's leadership is driven by the United States' position as the world's largest medical device market, supported by the presence of leading global corporations such as Medtronic, Abbott, and GE HealthCare. The region benefits from a robust reimbursement environment for advanced technologies and a highly sophisticated regulatory ecosystem administered by the FDA. Furthermore, the high level of healthcare expenditure and the rapid adoption of AI and robotic technologies in clinical settings further solidify North America's dominant market position.

Asia-Pacific is projected to witness the fastest growth during the forecast period. This rapid expansion is primarily driven by the rapidly expanding healthcare infrastructure across China, India, and Southeast Asia. The region's large and aging population is generating sustained demand for precision diagnostic and monitoring devices to manage chronic conditions. Furthermore, government initiatives to modernize healthcare systems and the growing domestic manufacturing base for medical devices are creating significant opportunities for both local and international players. Key regional hubs like Japan and South Korea remain at the forefront of robotic and imaging technology adoption.

Europe represents a significant market for precision medical devices, characterized by a strong emphasis on clinical research and high-quality healthcare delivery. Germany, the U.K., and France are the key regional hubs, hosting world-class medical institutions and material science leaders. The region is seeing increased adoption of connected health technologies and precision surgical tools, supported by evolving regulatory frameworks such as the EU MDR. Key companies in the European market include Siemens Healthineers (Germany) and Philips Healthcare (Netherlands).

Latin America and the Middle East & Africa are emerging markets for precision medical devices. In the MEA region, Israel and the UAE are significant demand centers for advanced diagnostic and robotic technologies. Latin America is seeing growing investment in healthcare infrastructure and a rising focus on managing the growing burden of non-communicable diseases through improved diagnostic and monitoring capabilities.

Key Players

The key players operating in the global precision medical devices market include Medtronic plc (Ireland), Siemens Healthineers AG (Germany), GE HealthCare Technologies Inc. (U.S.), Philips Healthcare (Netherlands), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Stryker Corporation (U.S.), Intuitive Surgical, Inc. (U.S.), Johnson & Johnson (MedTech) (U.S.), Becton, Dickinson and Company (BD) (U.S.), Roche Diagnostics (Switzerland), Dexcom, Inc. (U.S.), Zimmer Biomet Holdings (U.S.), ResMed Inc. (U.S.), and Masimo Corporation (U.S.).

Key Questions Answered in the Report-

  • What is the value of revenue generated from the global precision medical devices market?
  • At what rate is the precision medical devices demand projected to grow for the next 10 years?
  • What are the historical market sizes and growth rates of the global precision medical devices market?
  • What are the major factors impacting the growth of this market? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of device type, technology, application, end user, and connectivity are expected to create major traction for the vendors in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the precision medical devices market?
  • Who are the major players in the precision medical devices market? What are their specific offerings in this market?
  • What are the recent strategic developments in the global precision medical devices market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Precision Medical Devices Market Assessment -- by Device Type

  • Diagnostic Devices (Imaging Systems, Molecular & Genomic Diagnostics, Point-of-Care Diagnostics)
  • Monitoring Devices (Continuous Glucose Monitors, Cardiac Monitors, Remote Patient Monitoring, Wearable Health Devices)
  • Therapeutic Devices ( Laser-Based Treatment, Radiation Therapy, Drug Delivery Systems)
  • Surgical & Interventional Devices (Robotic Surgical Systems, Image-Guided Surgical Devices, Minimally Invasive Instruments)
  • Implantable Devices (Cardiac Implants, Orthopedic Implants, Neurostimulation Devices, Personalized/3D-Printed Implants)

Precision Medical Devices Market Assessment -- by Technology

  • Artificial Intelligence & Machine Learning
  • Robotics & Automation
  • Sensor & Biosensor Technologies
  • Imaging Technologies
  • 3D Printing & Additive Manufacturing

Precision Medical Devices Market Assessment -- by Application

  • Cardiology
  • Oncology
  • Neurology
  • Orthopedics
  • Diabetes Management
  • Respiratory Care
  • Others

Precision Medical Devices Market Assessment -- by End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Diagnostic Laboratories
  • Home Healthcare Settings
  • Research & Academic Institutes

Precision Medical Devices Market Assessment -- by Connectivity

  • Standalone Devices
  • Connected / IoT-Enabled Devices
  • Cloud-Integrated Devices

Precision Medical Devices Market Assessment -- by Geography

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Spain, Netherlands, Sweden, Switzerland, Rest of Europe)
  • Asia-Pacific (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Vietnam, Rest of Asia-Pacific)
  • Latin America (Brazil, Mexico, Argentina, Chile, Colombia, Rest of Latin America)
  • Middle East & Africa (UAE, Saudi Arabia, South Africa, Turkey, Israel, Rest of MEA)

TABLE OF CONTENTS

1. Introduction

  • 1.1 Market Definition
  • 1.2 Market Ecosystem
  • 1.3 Currency and Limitations
    • 1.3.1 Currency
    • 1.3.2 Limitations
  • 1.4 Key Stakeholders

2. Research Methodology

  • 2.1 Research Approach
  • 2.2 Data Collection & Validation Process
    • 2.2.1 Secondary Research
    • 2.2.2 Primary Research & Validation
      • 2.2.2.1 Primary Interviews with Experts
      • 2.2.2.2 Approaches for Country-/Region-Level Analysis
  • 2.3 Market Estimation
    • 2.3.1 Bottom-Up Approach
    • 2.3.2 Top-Down Approach
    • 2.3.3 Growth Forecast
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

3. Executive Summary

4. Market Overview

  • 4.1 Introduction
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
      • 4.2.1.1 Growing Adoption of Precision Medicine and Personalized Healthcare
      • 4.2.1.2 Increasing Demand for Minimally Invasive Procedures
      • 4.2.1.3 Advancements in Imaging, Robotics, and Sensor Technologies
      • 4.2.1.4 Rising Prevalence of Chronic Diseases
    • 4.2.2 Restraints
      • 4.2.2.1 High Cost of Advanced Precision Devices
      • 4.2.2.2 Complex Regulatory Approval Processes
      • 4.2.2.3 Integration Challenges with Healthcare IT Systems
    • 4.2.3 Opportunities
      • 4.2.3.1 Growth in Wearable and Remote Monitoring Devices
      • 4.2.3.2 Expansion of AI-Enabled Diagnostic Devices
      • 4.2.3.3 Increasing Adoption in Emerging Markets
      • 4.2.3.4 Development of Personalized Implantable Devices
    • 4.2.4 Challenges
      • 4.2.4.1 Data Accuracy and Interoperability Issues
      • 4.2.4.2 Cybersecurity Risks in Connected Devices
  • 4.3 Technology Landscape
    • 4.3.1 AI and Machine Learning in Medical Devices
    • 4.3.2 Robotics and Computer-Assisted Surgery
    • 4.3.3 Advanced Imaging Technologies
    • 4.3.4 Biosensors and Wearable Technologies
    • 4.3.5 3D Printing and Personalized Implants
  • 4.5 Value Chain Analysis
    • 4.5.1 Component Suppliers (Sensors, Chips, Materials)
    • 4.5.2 Device Manufacturers
    • 4.5.3 Software & AI Platform Providers
    • 4.5.4 Healthcare Providers
    • 4.5.5 Patients & End Users
  • 4.6 Regulatory and Standards Landscape
    • 4.6.1 FDA Medical Device Regulations
    • 4.6.2 EU MDR and CE Marking
    • 4.6.3 ISO Standards (ISO 13485, IEC 60601)
    • 4.6.4 Data Privacy Regulations (HIPAA, GDPR)
  • 4.7 Porter's Five Forces Analysis

5. Precision Medical Devices Market, by Device Type (Primary Segmentation)

  • 5.1 Introduction
  • 5.2 Diagnostic Devices
    • 5.2.1 Imaging Systems (MRI, CT, Ultrasound)
    • 5.2.2 Molecular & Genomic Diagnostic Devices
    • 5.2.3 Point-of-Care Diagnostic Devices
  • 5.3 Therapeutic Devices
    • 5.3.1 Laser-Based Treatment Devices
    • 5.3.2 Radiation Therapy Devices
    • 5.3.3 Drug Delivery Systems
  • 5.4 Monitoring Devices
    • 5.4.1 Continuous Glucose Monitors (CGM)
    • 5.4.2 Cardiac Monitoring Devices
    • 5.4.3 Remote Patient Monitoring Systems
    • 5.4.4 Wearable Health Devices
  • 5.5 Surgical & Interventional Devices
    • 5.5.1 Robotic Surgical Systems
    • 5.5.2 Image-Guided Surgical Devices
    • 5.5.3 Minimally Invasive Surgical Instruments
  • 5.6 Implantable Devices
    • 5.6.1 Cardiac Implants (Pacemakers, ICDs)
    • 5.6.2 Orthopedic Implants
    • 5.6.3 Neurostimulation Devices
    • 5.6.4 Personalized/3D-Printed Implants
  • 5.7 Other Precision Medical Devices

6. Precision Medical Devices Market, by Technology

  • 6.1 Introduction
  • 6.2 Artificial Intelligence & Machine Learning
  • 6.3 Robotics & Automation
  • 6.4 Sensor & Biosensor Technologies
  • 6.5 Imaging Technologies
  • 6.6 3D Printing & Additive Manufacturing

7. Precision Medical Devices Market, by Application

  • 7.1 Introduction
  • 7.2 Cardiology
  • 7.3 Oncology
  • 7.4 Neurology
  • 7.5 Orthopedics
  • 7.6 Diabetes Management
  • 7.7 Respiratory Care
  • 7.8 Others

8. Precision Medical Devices Market, by End User

  • 8.1 Introduction
  • 8.2 Hospitals & Clinics
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Diagnostic Laboratories
  • 8.5 Home Healthcare Settings
  • 8.6 Research & Academic Institutes

9. Precision Medical Devices Market, by Precision Level (Advanced Segmentation)

  • 9.1 Introduction
  • 9.2 Standard Precision Devices
  • 9.3 High-Precision Devices
  • 9.4 Ultra-Precision / Personalized Devices

10. Precision Medical Devices Market, by Connectivity

  • 10.1 Introduction
  • 10.2 Standalone Devices
  • 10.3 Connected / IoT-Enabled Devices
  • 10.4 Cloud-Integrated Devices

11. Precision Medical Devices Market, by Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 U.K.
    • 11.3.3 France
    • 11.3.4 Italy
    • 11.3.5 Spain
    • 11.3.6 Netherlands
    • 11.3.7 Sweden
    • 11.3.8 Switzerland
    • 11.3.9 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Australia
    • 11.4.6 Singapore
    • 11.4.7 Thailand
    • 11.4.8 Malaysia
    • 11.4.9 Indonesia
    • 11.4.10 Vietnam
    • 11.4.11 Rest of Asia-Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
    • 11.5.4 Chile
    • 11.5.5 Colombia
    • 11.5.6 Rest of Latin America
  • 11.6 Middle East & Africa
    • 11.6.1 UAE
    • 11.6.2 Saudi Arabia
    • 11.6.3 South Africa
    • 11.6.4 Turkey
    • 11.6.5 Israel
    • 11.6.6 Rest of Middle East & Africa

12. Competitive Landscape

  • 12.1 Overview
  • 12.2 Key Growth Strategies
  • 12.3 Competitive Benchmarking
  • 12.4 Competitive Dashboard
    • 12.4.1 Industry Leaders
    • 12.4.2 Market Differentiators
    • 12.4.3 Vanguards
    • 12.4.4 Emerging Companies
  • 12.5 Market Ranking/Positioning Analysis of Key Players, 2025

13. Company Profiles

  • 13.1 Medtronic plc
  • 13.2 Siemens Healthineers AG
  • 13.3 GE HealthCare Technologies Inc.
  • 13.4 Philips Healthcare
  • 13.5 Abbott Laboratories
  • 13.6 Boston Scientific Corporation
  • 13.7 Stryker Corporation
  • 13.8 Intuitive Surgical, Inc.
  • 13.9 Johnson & Johnson (MedTech)
  • 13.10 Becton, Dickinson and Company (BD)
  • 13.11 Roche Diagnostics
  • 13.12 Dexcom, Inc.
  • 13.13 Zimmer Biomet Holdings
  • 13.14 ResMed Inc.
  • 13.15 Masimo Corporation

14. Appendix

  • 14.1 Additional Customization
  • 14.2 Related Reports